Oculus Announces Initial Sites for Phase II Clinical Trial of Microcyn(R) Technology in Treatment of Mild Diabetic Foot Infections Mar 29, 2007
Oculus' Dermacyn(R) Wound Care Subject of 33-Patient Study Published in International Journal of Lower Extremity Wounds Mar 13, 2007
Oculus Innovative Sciences to Announce Fiscal Third Quarter 2007 Results on Wednesday, February 21 Feb 20, 2007
Oculus Innovative Sciences, Inc. Announces Exercise of Underwriters' Over-Allotment Option Feb 20, 2007